Trials / Completed
CompletedNCT02670603
A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis
A Prospective Randomized Controlled Trial of Evonail® Solution for Prevention or Treatment of Onycholysis in Breast Cancer Patients Who Received Neoadjuvant/Adjuvant Docetaxel Chemotherapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study is a prospective randomized controlled study of EVONAIL® solution for prevention or treatment of onycholysis in patients with breast cancer receiving docetaxel chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EVONAIL® solution |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-06-01
- Completion
- 2016-09-01
- First posted
- 2016-02-02
- Last updated
- 2017-04-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02670603. Inclusion in this directory is not an endorsement.